UNSPSC 41115810: Coagulation analyzer accessories or supplies

UNSPSC 41115810 Coagulation analyzer accessories or supplies is a Commodity code addressing laboratory diagnostic equipment consumables and support items that state and local health departments, hospital systems, and public health laboratories purchase to maintain and operate blood-coagulation testing platforms. Recent state and local opportunities show the code captures both routine reagent and consumable replenishment and sole-source service and supply renewals for proprietary analyzers. The Illinois Department of Public Health Division of Laboratories' August 2026 notice of intent to award a two-year sole-source contract to Clear Labs for reagent bundles and service coverage for Clear Dx System LR-SR instruments—valued at $1,904,475.72 with annual reagent volumes of 110 SARS-CoV-2 units and 215 Microbial Surveillance units plus preventive maintenance and repair support across Chicago and Springfield—exemplifies the scope. Issuing bodies soliciting under the code include state health departments and laboratory divisions, city and county public health programs, hospital networks, and independent school districts. The code sees activity from health-focused state agencies as primary buyers, with occasional municipal health departments and regional laboratory consortia participating.

Geographic activity concentrates in Illinois, Washington, Florida, Minnesota, Texas, and Georgia based on recent opportunities posted between April and October 2026. The State of Illinois Department of Public Health has been the most visible buyer, with cumulative prior purchases from Clear Labs dating to April 2023 totaling more than $4.4 million. Sourcewell's September 2026 RFP for Physical Health Products and Related Services—a cooperative purchasing vehicle with responses due October 20, 2026—establishes a multi-state contracting solution available to its Participating Entities across Minnesota and other jurisdictions, though the scope summary does not detail whether coagulation analyzers or related consumables are explicitly included. The limited visibility of this specific commodity in recent state and local notices suggests moderate deal flow; most opportunities cluster around sole-source renewals for incumbent diagnostic platforms rather than competitive procurements for new analyzer systems or generic reagent supplies.